|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01419 HUMAN HEALTH
Nominal 
0.820 0.000 (0.000%) | 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 342,351 | 8.412% | 315,788 | 295,190 | 681,274 | 388,544 |
| Cost of Sales | (182,881) | 9.464% | (167,070) | (154,684) | (213,434) | (173,049) |
| Gross Profit | 159,470 | 7.230% | 148,718 | 140,506 | 467,840 | 215,495 |
| 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 253 | -- | (179) | (760) | (1,175) | (388) | |
| Profit / (Loss) before Taxation | 22,654 | 12.897% | 20,066 | 23,934 | 325,092 | 108,226 | |
| Taxation | (3,756) | 15.783% | (3,244) | (3,901) | (56,980) | (17,798) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (646) | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 18,252 | 8.501% | 16,822 | 20,033 | 268,112 | 90,428 | |
| 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | (177) | -96.277% | (4,754) | (4,337) | 1,760 | 1,024 |
| Depreciation & Amortisation | 33,087 | 0.786% | 32,829 | 33,116 | 35,893 | 29,818 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/12 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/12 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 4.800 | 9.091% | 4.400 | 5.300 | 70.600 | 23.800 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.072 | -- | 2.032 | 2.014 | 2.360 | 1.200 |
| Remarks: | Real time quote last updated: 05/03/2026 10:25 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 18,252 |
| %Change | 8.501% |
| EPS / (LPS) | HKD 0.048 |
| NBV Per Share ($) | HKD 2.072 |